Mechanisms for PDGF, a serum cytokine, stimulating loss of corneal keratocyte crystallins

Cornea

Volumn 32, Issue 9, 2013, Pages 1269-1275

  Lagier, Adriana J ^a,b,e   Gordon, Gabriel M ^b,c   Katzman, Lee R ^b   Vasiliou, Vasilis ^d   Elizabeth Fini, M ^b,c  

^a FLORIDA GULF COAST UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Department of Biology   (United States)

Author keywords

aldehyde dehydrogenase; corneal keratocytes; platelet derived growth factor BB; signal transduction pathway; transketolase

Indexed keywords

ALDEHYDE DEHYDROGENASE; CRYSTALLIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSKETOLASE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CORNEA CELL; CULTURE MEDIUM; EXPERIMENTAL RABBIT; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ALDEHYDE DEHYDROGENASE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CORNEAL KERATOCYTES; ENZYME INHIBITORS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PROTO-ONCOGENE PROTEINS C-SIS; RABBITS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSKETOLASE;

EID: 84883293187     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318296e0b9     Document Type: Article

References (51)

1. Desmouliere A, Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum Press; 1996:391-423.
2. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994;124:401-404. (Pubitemid 24064453)
3. Bisgaard HC, Thorgeirsson SS. Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases. Clin Lab Med. 1996;16: 325-339. (Pubitemid 26185270)
4. Fini ME, Stramer BM. How the cornea heals: cornea-specific repair mechanisms impacting on surgical outcomes. Cornea. 2005;24(suppl 8): S2-S11. (Pubitemid 41688549)
5. Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature. 2008;453:314-321. (Pubitemid 351693137)
6. McCallion RL, Ferguson MWJ. Fetal wound repair. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum Press; 1996:561-600.
7. Cintron C, Kublin CL. Regeneration of corneal tissue. Dev Biol. 1977;61: 346-357. (Pubitemid 8248686)
8. Matsuda H, Smelser GK. Electron microscopy of corneal wound healing. Exp Eye Res. 1973;16:427-442.
9. Weimar V. Healing Processes in the Cornea. Oxford, United Kingdom: Blackwell Scientific Publications; 1960.
10. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999;18:529-551. (Pubitemid 29126966)
11. Jester JV, Barry-Lane PA, Cavanagh HD, et al. Induction of alphasmooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516. (Pubitemid 26271790)
12. Funderburgh JL, Chandler JW. Proteoglycans of rabbit corneas with nonperforating wounds. Invest Ophthalmol Vis Sci. 1989;30:435-442. (Pubitemid 19100671)
13. Beales MP, Funderburgh JL, Jester JV, et al. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40:1658-1663. (Pubitemid 29297138)
14. Berryhill BL, Kader R, Kane B, et al. Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Invest Ophthalmol Vis Sci. 2002;43:3416-3421. (Pubitemid 35334348)
15. Garana RM, Petroll WM, Chen WT, et al. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci. 1992;33:3271-3282.
16. Jester JV, Barry PA, Lind GJ, et al. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest Ophthalmol Vis Sci. 1994;35:730-743. (Pubitemid 24078133)
17. Berryhill BL, Kane B, Stramer BM, et al. Increased SPARC accumulation during corneal repair. Exp Eye Res. 2003;77:85-92. (Pubitemid 36776277)
18. Cook JR, Mody MK, Fini ME. Failure to activate transcription factor NF-kappaB in corneal stromal cells (keratocytes). Invest Ophthalmol Vis Sci. 1999;40:3122-3131.
19. West-Mays JA, Sadow PM, Tobin TW, et al. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop. Invest Ophthalmol Vis Sci. 1997;38:1367-1379. (Pubitemid 27278556)
20. West-Mays JA, Strissel KJ, Sadow PM, et al. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1 alpha autocrine loop. Proc Natl Acad Sci USA. 1995;92:6768-6772.
21. Berryhill BL, Beales MP, Hassell JR. Production of prostaglandin D synthase as a keratan sulfate proteoglycan by cultured bovine keratocytes. Invest Ophthalmol Vis Sci. 2001;42:1201-1207. (Pubitemid 32381958)
22. Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 2003;278:45629-45637. (Pubitemid 37432705)
23. Estey T, Chen Y, Carpenter JF, et al. Structural and functional modifications of corneal crystallin ALDH3A1 by UVB light. PLoS One. 2010; 5:e15218.
24. Estey T, Piatigorsky J, Lassen N, et al. ALDH3A1: a corneal crystallin with diverse functions. Exp Eye Res. 2007;84:3-12. (Pubitemid 44792047)
25. Lassen N, Black WJ, Estey T, et al. The role of corneal crystallins in the cellular defense mechanisms against oxidative stress. Semin Cell Dev Biol. 2008;19:100-112.
26. Jester JV, Moller-Pedersen T, Huang J, et al. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J Cell Sci. 1999;112(pt 5): 613-622. (Pubitemid 29141981)
27. Piatigorsky J. Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the "refracton" hypothesis. Cornea. 2001;20:853-858. (Pubitemid 33029485)
28. Stramer BM, Fini ME. Uncoupling keratocyte loss of corneal crystallin from markers of fibrotic repair. Invest Ophthalmol Vis Sci. 2004;45: 4010-4015. (Pubitemid 39411155)
29. Stramer BM, Zieske JD, Jung JC, et al. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest Ophthalmol Vis Sci. 2003;44:4237-4246. (Pubitemid 37186257)
30. Pappa A, Sophos NA, Vasiliou V. Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals. Chem Biol Interact. 2001;130-132:181-191. (Pubitemid 32295813)
31. Fenteany G, Standaert RF, Reichard GA, et al. A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc Natl Acad Sci USA. 1994;91:3358-3362.
32. Stramer BM, Cook JR, Fini ME, et al. Induction of the ubiquitin-proteasome pathway during the keratocyte transition to the repair fibroblast phenotype. Invest Ophthalmol Vis Sci. 2001;42:1698-1706. (Pubitemid 32652342)
33. Manzer R, Pappa A, Estey T, et al. Ultraviolet radiation decreases expression and induces aggregation of corneal ALDH3A1. Chem Biol Interact. 2003;143-144:45-53. (Pubitemid 36253578)
34. Buchdunger E, Cioffi CL, Law N, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000;295:139-145.
35. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Front Biosci. 2002;7:d1720-d1726.
36. Stramer BM, Austin JS, Roberts AB, Fini ME. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3. J Cell Physiol. 2005;203:226-232. (Pubitemid 40328189)
37. Ciuclan L, Ehnert S, Ilkavets I, et al. TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I. J Hepatol. 2010;52:407-416.
38. Tallquist M, Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev. 2004;15:205-213. (Pubitemid 38781046)
39. Lei H, Velez G, Kazlauskas A. Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53. Mol Cell Biol. 2011;31:1788-1799.
40. Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995;81:727-736.
41. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298: 1911-1912. (Pubitemid 35425238)
42. Chua BT, Gallego-Ortega D, Ramirez de Molina A, et al. Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells. Mol Cancer. 2009;8:131.
43. Aikin R, Maysinger D, Rosenberg L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology. 2004;145:4522-4531. (Pubitemid 39281444)
44. Wei L, Liu Y, Kaneto H, et al. JNK regulates serotonin-mediated proliferation and migration of pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2010;298:L863-L869.
45. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005;17:596-603. (Pubitemid 41540408)
46. Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991;253:905-909. (Pubitemid 21917235)
47. Ghosh D. Status of the transcription factors database (TFD). Nucleic Acids Res. 1993;21:3117-3118. (Pubitemid 23223612)
48. Bogoyevitch MA, Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev. 2006;70:1061-1095. (Pubitemid 44958264)
49. Terme JM, Lhermitte L, Asnafi V, et al. TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation. Blood. 2009;113:6695-6698.
50. Weidenfeld-Baranboim K, Koren L, Aronheim A. Phosphorylation of JDP2 on threonine-148 by the c-Jun N-terminal kinase targets it for proteosomal degradation. Biochem J. 2011;436:661-669.
51. Schirmer A, Kennedy J, Murli S, et al. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides. Proc Natl Acad Sci USA. 2006;103:4234-4239.